DigestRedComo funciona
Red
/
Empresas
Vi
No verificado

Virion Therapeutics, LLC

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaIndustriaSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa
29/05/2026
Eventos
Ferias y Congresos
Industria
Salud
VIH, SIDA y enfermedades autoinmunes
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Continued HBsAg Declines, Without Rebound, Up to Two Plus Years, After a Single VRON-0200 Dose, From its Phase 1b Study at EASL 2026
Fuente
Virion Therapeutics, LLC
Editor
Business Wire
1.00
0
09/11/2025
Biotecnología
VIH, SIDA y enfermedades autoinmunes
Salud
Farmacéutica
Medicina - Varios
Industria
Eventos
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Sustained and Continued HBsAg Declines up to One Year After a Single VRON-0200 Dose From its Phase 1b Study at AASLD’s The Liver Meeting® 2025
Fuente
Virion Therapeutics, LLC
Editor
Business Wire
1.00
0
07/10/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Eventos
Industria
Virion Therapeutics Announces Upcoming Clinical Presentation Highlighting VRON-0200 Study Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2025
Fuente
Virion Therapeutics, LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0